MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-29-2025
Agilent Technologies EV/EBITDA Ratio 2011-2026 | A
Annual EV/EBITDA Ratio Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 27.4 | 32 | 22.4 | 20 | 20.5 | 16.2 | 17.5 | 11.5 | 9.89 | 6.72 | 6.02 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32 | 6.02 | 17.3 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Anixa Biosciences
ANIX
|
-2.25 | $ 3.03 | -2.26 % | $ 98.3 K |  USA |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Brainsway Ltd.
BWAY
|
-43.6 | $ 23.35 | -2.91 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 34.5 | 2.16 % | $ 371 M |  China |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.29 | -12.26 % | $ 1.64 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | USA |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 39.74 | 1.48 % | $ 1.1 B | USA |
 |
Danaher Corporation
DHR
|
20.1 | $ 219.29 | -0.08 % | $ 160 B | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
39.5 | $ 73.31 | -0.93 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 20.55 | -1.23 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
-2.38 | $ 109.48 | -2.35 % | $ 4.32 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | $ 102.41 | 0.1 % | $ 19 B | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 10.2 | -0.97 % | $ 289 M | Israel |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 26.19 | -0.19 % | $ 792 M | USA |
 |
Guardant Health
GH
|
-28.8 | $ 113.17 | 2.43 % | $ 13.9 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
45.3 | $ 672.84 | -0.57 % | $ 55.5 B | USA |
 |
Illumina
ILMN
|
70.5 | $ 144.81 | -3.26 % | $ 23 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
24.1 | $ 230.33 | -2.19 % | $ 41.8 B | USA |
 |
Charles River Laboratories International
CRL
|
22 | $ 210.51 | -0.59 % | $ 10.8 B | USA |
 |
Lantheus Holdings
LNTH
|
-187 | $ 66.91 | 0.34 % | $ 4.63 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 186.45 | 2.27 % | $ 20.7 B | USA |
|
Biodesix
BDSX
|
-4.25 | $ 10.11 | 4.66 % | $ 1.31 B | USA |
 |
Precipio
PRPO
|
-1.8 | $ 24.07 | -0.78 % | $ 31.2 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 271.34 | 0.56 % | $ 22.8 B | USA |
 |
ICON Public Limited Company
ICLR
|
38 | $ 181.44 | -2.39 % | $ 15 B |  Irlanda |
 |
Medpace Holdings
MEDP
|
30.7 | $ 582.66 | -1.76 % | $ 18 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
55.6 | $ 28.66 | -2.02 % | $ 20 B | Niderland |
 |
Biomerica
BMRA
|
-6.24 | $ 2.41 | 0.84 % | $ 5.54 M | USA |
 |
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M | USA |
 |
Bioventus
BVS
|
26.4 | $ 7.86 | 0.51 % | $ 492 M | USA |
 |
Quidel Corporation
QDEL
|
9.16 | $ 27.24 | -0.62 % | $ 1.15 B | USA |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | Israel |